Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1189.14%
operating margin TTM
-1175.68%
revenue TTM
38.67 Million
revenue per share TTM
0.39$
valuation ratios | |
|---|---|
| pe ratio | -1.50 |
| peg ratio | -0.14 |
| price to book ratio | 1.96 |
| price to sales ratio | 18.46 |
| enterprise value multiple | -1.65 |
| price fair value | 1.96 |
profitability ratios | |
|---|---|
| gross profit margin | 94.21% |
| operating profit margin | -1175.68% |
| pretax profit margin | -1194.05% |
| net profit margin | -1189.14% |
| return on assets | -89.41% |
| return on equity | -100.13% |
| return on capital employed | -101.84% |
liquidity ratios | |
|---|---|
| current ratio | 6.22 |
| quick ratio | 6.22 |
| cash ratio | 0.61 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 76.99 |
| days of payables outstanding | 1,970.10 |
| cash conversion cycle | -1,893.11 |
| receivables turnover | 4.74 |
| payables turnover | 0.19 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.18 |
| debt equity ratio | 0.26 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.21 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -3.76 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.06 |
| cash per share | 1.23 |
| operating cash flow per share | -1.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.76 |
| short term coverage ratios | -78.67 |
| capital expenditure coverage ratio | -260.29 |
Frequently Asked Questions
When was the last time Caribou Biosciences, Inc. (NASDAQ:CRBU) reported earnings?
Caribou Biosciences, Inc. (CRBU) published its most recent earnings results on 07-05-2026.
What is Caribou Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Caribou Biosciences, Inc. (NASDAQ:CRBU)'s trailing twelve months ROE is -100.13%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Caribou Biosciences, Inc. (CRBU) currently has a ROA of -89.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CRBU's net profit margin stand at?
CRBU reported a profit margin of -1189.14% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CRBU's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.22 in the most recent quarter. The quick ratio stood at 6.22, with a Debt/Eq ratio of 0.26.